785
Views
61
CrossRef citations to date
0
Altmetric
Original Article

Poly(ethylene glycol)-block-poly(d,l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery

, , , , , , & show all
Pages 197-203 | Received 14 Feb 2010, Accepted 02 Apr 2010, Published online: 06 May 2010
 

Abstract

In this study, angiopep with high transcytosis capacity and parenchymal accumulation was used as a novel ligand for the brain-targeting delivery of poly(ethylene glycol)-block-poly(d,l-lactide acid) (PEG-PLA) micelles. Angiopep-2 was synthesized by solid-phase peptide synthesis, and then conjugated with maleimide-PEG-PLA to form angiopep-PEG-PLA. The micelles composed of methoxy-PEG-PLA (mPEG-PLA) and angiopep-PEG-PLA was prepared by film-hydration method. Near-infrared fluorescence dye, DiR was loaded into micelles to evaluate the brain-targeting ability of micelles with or without angiopep modification by near-infrared fluorescence imaging in vivo and ex vivo. Significant near-infrared (NIR) fluorescent signal was detected in the brain after angiopep-anchored micelles administration and further confirmed by imaging the whole brain and brain slices, compared with that of the micelles without modification. 125I-radiolabeled angiopep-PEG-PLA micelles after intravenous administration in mice showed high brain accumulation for up to 24 h. These results indicate that angiopep-modified PEG-PLA micelle is a promising brain-targeting nanocarrier for lipophilic drugs.

Acknowledgements

The authors acknowledged Prof. Jianhua Zhu and Jun Qian (Fudan University, China) for their help in radiolabeled experiment. We also greatly acknowledged Prof. Jiandong Ding and Doctor Guangtao Chang for their help in the synthesis of PEG-PLA copolymers.

Declaration of interest

This work was supported by National Basic Research Program of China (973 Program) 2007CB935800, the “National Science and Technology Major Project” 2009ZX09310-006 and “Shanghai Postdoctoral Scientific Program” 10R21410800.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.